Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
K&N Engineering recapitalization
We advised K&N in connection with its recapitalization
CStone Pharmaceuticals HK$392.9 million placing of new shares
We advised CStone Pharmaceuticals on the placement
Sun Country Airlines $103.69 million secondary offering
The shares are listed on the Nasdaq Global Select Market
Atlas Air $850 million senior secured notes offering
The high-yield notes are part of the financing for an Apollo-led investor group’s acquisition of Atlas Air
Pepkor Holdings ZAR 4.9 billion secondary offering
The accelerated bookbuild transaction represented approximately 7.2% of Pepkor’s issued share capital
Export Development Canada $3.5 billion global bond offering
The investment-grade bonds are due 2028
Uniti Group $2.6 billion notes offering
We advised Uniti on its high-yield secured notes offering
Bed Bath & Beyond ABL amendment and $1.025 billion equity offering
We advised the ABL agent in connection with the transaction
IONOS Group €447 million IPO
The shares are listed on the Frankfurt Stock Exchange
Intel $11 billion senior notes offering
The investment-grade offering comprises seven tranches of notes